Holen Sie sich die Stockscreener-App
324.64
7.32%
-25.56
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$350.20
Offen:
$322.405
24-Stunden-Volumen:
6.98M
Relative Volume:
0.65
Marktkapitalisierung:
$405.03B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
61.28
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
-25.10%
1M Leistung:
+7.01%
6M Leistung:
+59.82%
1J Leistung:
+230.71%
1-Tages-Spanne:
$313.10
$330.75
1-Wochen-Bereich:
$313.10
$415.49
52-Wochen-Spanne:
$90.73
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
323.88 | 439.46B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,741.97 | 681.93B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
544.34 | 478.79B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
217.49 | 307.69B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
338.77 | 57.78B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Why is Lam Research stock tumbling today? - Investing.com
Nasdaq Weakness Shows AI Stocks Are Losing Their Easy Momentum - Investing.com
Form 4 Lam Research Corp For: 6 July By Investing.com - Investing.com Canada
Lam Research CEO Archer reports $11.7m in stock sales - Investing.com
Susquehanna Lifts PT on Lam Research (LRCX) – Here’s Why - Insider Monkey
Is Lam Research (LRCX) One of the Best Stocks on the Rise to Invest In? - Yahoo Finance
Goldman Sachs Adjusts Lam Research Price Target to $380 From $290 - Moomoo
What You Need to Know Ahead of Lam Research's Earnings Release - Barchart.com
Why is Lam Research stock surging today? - Investing.com
Lam Research Corporation $LRCX Shares Bought by Boston Trust Walden Corp - MarketBeat
Vltava Fund: Lam Research (LRCX) Is Overvalued - Yahoo Finance
XSWX:LRCX Dividend: Does Lam Research Corp Pay a Dividend? - GuruFocus
Lam Research Corp (XSWX:LRCX) Stock News, Headlines & Updates - GuruFocus
Lam Research Corp (XSWX:LRCX) Stock Price & 30 Year Financial Data - GuruFocus
Lam Research Corp (XSWX:LRCX) Stock Price, Trades & News - GuruFocus
Lam Research Corp Stock Operating Data - GuruFocus
Lam Research Corp (LRCX) Stock Down 10.2% but Still Overvalued -- GF Score: 85/100 - GuruFocus
Lam Research Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Lam Research Corp Stock (LRCX) Moved Down by 7.40% on Jul 2: What Investors Need To Know - TradingKey
The Zacks Analyst Blog Highlights AMD, Lam Research, Cisco Systems, Perma-Pipe international and AstroNova - Yahoo Finance
Top Analyst Reports for AMD, Lam Research & Cisco - Yahoo Finance
Lam Research Corp Price, LRCX Price, Live Charts, and Marketcap - Coinbase
Lam Research Corp. stock outperforms competitors on strong trading day - MSN
Why is Lam Research stock rallying today? By Investing.com - Investing.com Nigeria
Lam Research Corp Stock (LRCX) Moved Down by 8.94% on Jul 1: Drivers Behind the Movement - TradingKey
Lam Research (NASDAQ:LRCX) Shares Gap DownWhat's Next? - MarketBeat
Lam Research highlights chip-equipment demand as investors weigh long-term cycle - AD HOC NEWS
Lam Research Stock Surges 154% in H1'26: Should You Buy More or Exit? - Yahoo Finance
Can AI Demand Help Lam Research Hit New Highs for Gross Margin in Q4? - Zacks Investment Research
Could Lam Research Be the Next $1 Trillion Company? - Intellectia AI
Nvidia CEO Predicts Marvell as Next Trillion-Dollar Company - Intellectia AI
Why is Lam Research stock surging today? By Investing.com - Investing.com Australia
Lam Research Is Maintained at Positive by Susquehanna - Moomoo
Lam Research Corp Stock (LRCX) Moved Up by 4.98% on Jun 30: What Signal Does It Send? - TradingKey
Applied Materials and Lam Research lead chip equipment rebound on AI memory demand; Super Micro tumbles 8% on Taiwan raids, SOXX +4.1% - StartupHub.ai
Lam Research (NASDAQ:LRCX) Shares Up 8.4%Should You Buy? - MarketBeat
Lam Research Corp (LRCX) Stock Up 8.4% but GF Value Says Overval - GuruFocus
Lam Research (NASDAQ:LRCX) Sets New 1-Year HighTime to Buy? - MarketBeat
Lam Research stock hits all-time high at $409.8 USD - Investing.com
Lam Research stock hits all-time high at $409.8 USD By Investing.com - Investing.com South Africa
Lam Research Corp Stock (LRCX) Moved Up by 6.62% on Jun 29: Drivers Behind the Movement - TradingKey
Lam Research Is Maintained at Overweight by Cantor Fitzgerald - Moomoo
Susquehanna Adjusts Price Target on Lam Research to $475 From $385, Maintains Positive Rating - Moomoo
Cantor Fitzgerald raises Lam Research stock price target on share gains - Investing.com
Lam Research (LRCX): BofA Raises Its Target by $150 as Chip Equipment Spending Heads Toward $250 Billion - Insider Monkey
Why is Lam Research stock climbing today? - Investing.com UK
Why is Lam Research stock climbing today? By Investing.com - Investing.com South Africa
Lam Research (LRCX): Citi Raises Target by $135 on a Multi-Year Chip Manufacturing Investment Boom - Insider Monkey
Portus Wealth Advisors LLC Decreases Position in Lam Research Corporation $LRCX - MarketBeat
China foundries pose no immediate threat to Samsung, TSMC, Lam founder says - The Korea Economic Daily Global Edition
BofA Raises PT on Lam Research (LRCX), Keeps a Buy Rating - Insider Monkey
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Jul 02 '26 |
Sale |
390.01 |
30,000 |
11,700,300 |
1,075,966 |
9.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):